HERZUMA
Active substance: trastuzumab
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TRASTUZUMAB 150 mg/7.15mL
United StatesActive
Marketing holder: Cephalon, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- TRASTUZUMAB · 150 mg/7.15mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 15 |
|
| EU 13 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e67-7b0e-a475-c94e8e86d5fe,01a120c3-2f88-7b71-bc92-d9a3cefa3379,01a120c3-5448-714a-8402-be91539e47d0,01a120c3-56a6-7833-aa05-aec8042dc567,01a120c3-61c5-7bc4-8148-752ad101b5bd;count=12 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8fdb-78fd-a8b1-3722a1f8352f,01a1208d-c698-7897-9564-a11769fcbf84,01a1208e-b619-79c4-b63b-10c76a02b410,01a1208f-47cc-7dac-8ae0-de20c47dbbe7,01a12090-4783-790f-b38c-87c40df14627;count=11 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 63459-303
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 63459-303 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63459-303 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63459-303 · Verified 2026-10-09 · open in source